)
COVID-19 vaccine: Bangladesh signs deal with Serum Institute of India
Bangladesh has signed a crucial deal with the Serum Institute of India to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for COVID-19.
Bangladesh has signed a crucial deal with the Serum Institute of India to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for COVID-19.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)